3D domain‐swapped human cystatin C with amyloidlike intermolecular β‐sheets

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Proteins: Structure, Function, and Bioinformatics

• Publication date

  2005-11-15

• Fields of study

  Biology, Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1002/prot.20633PMID 16170782
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Domain swapping of a llama VHH domain builds a crystal-wide beta-sheet structure.

  2004cited by this paper
• MEROPS: the peptidase database

  2004cited by this paper
• Domain swapping in N-truncated human cystatin C.

  2004cited by this paper
• Prevention of Domain Swapping Inhibits Dimerization and Amyloid Fibril Formation of Cystatin C

  2004cited by this paper
• Domain swapping of a llama VHH domain builds a crystal‐wide β‐sheet structure

  2004cited by this paper
• Cystatins.

  2003cited by this paper
• Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process

  2003cited by this paper
• Structures of the two 3D domain‐swapped RNase A trimers

  2002cited by this paper
• Protein folding and three-dimensional domain swapping: astrained relationship?

  2002cited by this paper
• Protein folding and three-dimensional domain swapping: a strained relationship?

  2002cited by this paper
• Structural studies of the scrapie prion protein by electron crystallography

  2002cited by this paper
• Crystal structure of the human prion protein reveals a mechanism for oligomerization

  2002cited by this paper
• The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids

  2001cited by this paper
• 3D domain swapping, protein oligomerization, and amyloid formation.

  2001cited by this paper
• A domain-swapped RNase A dimer with implications for amyloid formation

  2001cited by this paper
• Design of three-dimensional domain-swapped dimers and fibrous oligomers.

  2001cited by this paper
• Three‐dimensional domain swapping in the folded and molten‐globule states of cystatins, an amyloid‐forming structural superfamily

  2001cited by this paper
• Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping

  2001cited by this paper
• Hereditary cystatin C amyloid angiopathy

  2000cited by this paper
• Expression of a selenomethionyl derivative and preliminary crystallographic studies of human cystatin C

  1999cited by this paper
• Inhibition of Mammalian Legumain by Some Cystatins Is Due to a Novel Second Reactive Site*

  1999cited by this paper
• Crystallography & NMR system: A new software suite for macromolecular structure determination.

  1998cited by this paper
• Oligomer formation by 3D domain swapping: a model for protein assembly and misassembly.

  1997cited by this paper
• Align : A program to superimpose protein coordinates, accounting for insertions and deletions

  1997cited by this paper
• MOLREP: an Automated Program for Molecular Replacement

  1997cited by this paper
• Common core structure of amyloid fibrils by synchrotron X-ray diffraction.

  1997cited by this paper
• The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.

  1997cited by this paper
• Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• MOLMOL: a program for display and analysis of macromolecular structures.

  1996cited by this paper
• Folding-related Dimerization of Human Cystatin C (*)

  1996cited by this paper
• 3D domain swapping: A mechanism for oligomer assembly

  1995cited by this paper
• Increased body temperature accelerates aggregation of the Leu-68-->Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy.

  1994cited by this paper
• Domain swapping: entangling alliances between proteins.

  1994cited by this paper
• PROCHECK: a program to check the stereochemical quality of protein structures

  1993cited by this paper
• Conformational variability of chicken cystatin. Comparison of structures determined by X-ray diffraction and NMR spectroscopy.

  1993cited by this paper
• Improved methods for building protein models in electron density maps and the location of errors in these models.

  1991cited by this paper
• Immunohistochemical characterization of cerebrovascular amyloid in 46 autopsied cases using antibodies to beta protein and cystatin C.

  1990cited by this paper
• The 2.0 A X‐ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases.

  1988cited by this paper
• Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C).

  1986cited by this paper
• The disulphide bridges of human cystatin C (γ‐trace) and chicken cystatin

  1984cited by this paper
• Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis.

  1982cited by this paper
• Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

  1980cited by this paper
• Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts).

  1980cited by this paper
• Solvent content of protein crystals.

  1968cited by this paper

• Comprehensive Analysis of Interactions between Human Serum Albumin and Human Cystatin C – Two Proteins Present in Body Fluids

  2025cites this paper
• The influence of a dicationic surfactant on the aggregation process of the IVAGVN peptide derived from the human cystatin C sequence (56–61)

  2025cites this paper
• Copper interaction with cystatin C: effects on protein structure and oligomerization

  2024cites this paper
• Dominant CST3 variants cause adult onset leukodystrophy without amyloid angiopathy.

  2024cites this paper
• Domain swapping: a mathematical model for quantitative assessment of structural effects

  2024cites this paper
• Comprehensive perspective towards the management of proteinopathies by elucidating protein misfolding and aggregation.

  2023cites this paper
• Human cystatin C induces the disaggregation process of selected amyloid beta peptides: a structural and kinetic view

  2023cites this paper
• Identification of a Steric Zipper Motif in the Amyloidogenic Core of Human Cystatin C and Its Use for the Design of Self-Assembling Peptides

  2022cites this paper
• Oligomerization of Human Cystatin C—An Amyloidogenic Protein: An Analysis of Small Oligomeric Subspecies

  2022cites this paper
• In Silico Therapeutic Peptide Design Against Pathogenic Domain Swapped Human Cystatin C Dimer

  2021cites this paper
• In Silico Therapeutic Peptide Design Against Pathogenic Domain Swapped Human Cystatin C Dimer

  2021cites this paper
• Computational Enzyme Stabilization Can Affect Folding Energy Landscapes and Lead to Catalytically Enhanced Domain-Swapped Dimers

  2021cites this paper
• NAC blocks Cystatin C amyloid complex aggregation in a cell system and in skin of HCCAA patients

  2021cites this paper
• Cystatin M/E (Cystatin 6): A Janus-Faced Cysteine Protease Inhibitor with Both Tumor-Suppressing and Tumor-Promoting Functions

  2021cites this paper
• Maturation of the functional mouse CRES amyloid from globular form

  2020cites this paper
• The effect of three polyphenols and some other anti-oxidant substances on amyloid fibril formation by human cystatin C.

  2020cites this paper
• The Influence of the Mixed DPC:SDS Micelle on the Structure and Oligomerization Process of the Human Cystatin C

  2020cites this paper
• Double Domain Swapping in Human γC and γD Crystallin Drives Early Stages of Aggregation

  2020cites this paper
• NMR and crystallographic structural studies of the extremely stable monomeric variant of human cystatin C with single amino acid substitution

  2019cites this paper
• The identification of discontinuous epitope in the human cystatin C - Monoclonal antibody HCC3 complex.

  2019cites this paper
• PrP (58–93) peptide from unstructured N-terminal domain of human prion protein forms amyloid-like fibrillar structures in the presence of Zn2+ ions

  2019cites this paper
• The domain swapping of human cystatin C induced by synchrotron radiation

  2019cites this paper
• Structural Characterization of Covalently Stabilized Human Cystatin C Oligomers

  2019cites this paper
• Synthesis and physicochemical studies of amyloidogenic hexapeptides derived from human cystatin C

  2018cites this paper
• Cosolvent Effects on the Growth of Protein Aggregates Formed by a Single Domain Globular Protein and an Intrinsically Disordered Protein

  2018cites this paper
• Intracerebroventricular administration of Cystatin C ameliorates disease in SOD1‐linked amyotrophic lateral sclerosis mice

  2018cites this paper
• Cyclic trimer of human cystatin C, an amyloidogenic protein - molecular dynamics and experimental studies

  2018cites this paper
• Overall conformation of covalently stabilized domain-swapped dimer of human cystatin C in solution

  2017cites this paper
• Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.

  2017cites this paper
• Direct Conversion of an Enzyme from Native-like to Amyloid-like Aggregates within Inclusion Bodies.

  2017cites this paper
• The enigma of the near-symmetry of proteins: Domain swapping

  2017cites this paper
• Crystallographic studies on protein misfolding: Domain swapping and amyloid formation in the SH3 domain.

  2016cites this paper
• Understanding protein domain-swapping using structure-based models of protein folding

  2016cites this paper
• Application of amide hydrogen/deuterium exchange mass spectrometry for epitope mapping in human cystatin C

  2016cites this paper
• Isolation and characterization of autoantibodies against human cystatin C

  2016cites this paper
• Protein Aggregation and Its Prediction

  2015cites this paper
• Multifaceted Roles of Crystallography in Modern Drug Discovery

  2015cites this paper
• The Landscape of Intertwined Associations in Homooligomeric Proteins.

  2015cites this paper
• Exploring the 'aggregation-prone' core of human Cystatin C: A structural study.

  2015influential citation
• Structural Basis for the Immunomodulatory Function of Cysteine Protease Inhibitor from Human Roundworm Ascaris lumbricoides

  2014cites this paper
• Micelle-Catalyzed Domain Swapping in the Cytoplasmic Domain of E. coli Rhomboid Protease

  2014cites this paper
• How to Get Insight into Amyloid Structure and Formation from Infrared Spectroscopy

  2014cites this paper
• Non-Crystalline Systems

  2014cites this paper
• Fertility Defects in Mice Expressing the L68Q Variant of Human Cystatin C

  2014cites this paper
• Electrostatic Effects in the Folding of the SH3 Domain of the c-Src Tyrosine Kinase: pH-Dependence in 3D-Domain Swapping and Amyloid Formation

  2014cites this paper
• Structural characterization of V57D and V57P mutants of human cystatin C, an amyloidogenic protein.

  2013influential citation
• Molecular Mechanisms in Amyloid Disorders. Novel Treatment Options in Hereditary Cystatin C Amyloid Angiopathy.

  2013cites this paper
• Stabilization, Characterization, and Selective Removal of Cystatin C Amyloid Oligomers*

  2013cites this paper
• Structural and functional analysis of the pro-domain of human cathelicidin, LL-37.

  2013cites this paper
• Steered molecular dynamics simulation of the binding of the β2 and β3 regions in domain-swapped human cystatin C dimer

  2013influential citation
• Cystatin SN neutralizes the inhibitory effect of cystatin C on cathepsin B activity

  2013cites this paper
• Evaluation of Cystatin C as A Predictor of Coronary Artery Disease in Type 2 Diabetes

  2013cites this paper
• X‐ray crystallography and NMR studies of domain‐swapped canecystatin‐1

  2013cites this paper
• Cystatin C: an emerging biomarker in cardiovascular disease.

  2013cites this paper
• Implications of 3D domain swapping for protein folding, misfolding and function.

  2012cites this paper
• Functional repertoire, molecular pathways and diseases associated with 3D domain swapping in the human proteome

  2012cites this paper
• Interaction of serum amyloid A with human cystatin C—identification of binding sites

  2012cites this paper
• 3.8 Protein and Nucleic Acid Folding: Domain Swapping in Proteins

  2012cites this paper
• Ribonuclease A suggests how proteins self‐chaperone against amyloid fiber formation

  2012cites this paper
• Steered molecular dynamics simulations on the binding of the appendant structure and helix-β2 in domain-swapped human cystatin C dimer

  2012cites this paper
• Domain swapping and amyloid fibril conformation

  2012cites this paper
• STRUCTURAL STUDIES OF COVALENTLY STABILISED OLIGOMERS OF HUMAN CYSTATIN C

  2012cites this paper
• Crystal structure of tarocystatin–papain complex: implications for the inhibition property of group-2 phytocystatins

  2011cites this paper
• The impact of solubility and electrostatics on fibril formation by the H3 and H4 histones

  2011cites this paper
• Identification of the epitope for anti‐cystatin C antibody

  2011cites this paper
• Early diagnostics of kidney damage in longstanding rheumatoid arthritis and amyloidosis

  2011cites this paper
• Crystallization and preliminary X-ray diffraction analysis of Val57 mutants of the amyloidogenic protein human cystatin C.

  2011cites this paper
• Amyloid-like Fibrils from a Domain-swapping Protein Feature a Parallel, in-Register Conformation without Native-like Interactions*

  2011cites this paper
• 3D domain swapping - implications for conformational disorders and ways of control

  2011cites this paper
• Identification of the epitope for anti-cystatin

  2011cites this paper
• Mechanisms of amyloid fibril formation – focus on domain‐swapping

  2011cites this paper
• A single mutation at the sheet switch region results in conformational changes favoring lambda6 light-chain fibrillogenesis.

  2010cites this paper
• Crystal structure of human cystatin C stabilized against amyloid formation

  2010cites this paper
• CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE.

  2010cites this paper
• Hinge-loop mutation can be used to control 3D domain swapping and amyloidogenesis of human cystatin C.

  2010cites this paper
• The crystal structures of two salivary cystatins from the tick Ixodes scapularis and the effect of these inhibitors on the establishment of Borrelia burgdorferi infection in a murine model

  2010cites this paper
• Production of Cystatin C Wild Type and Stabilized Mutants

  2010cites this paper
• Domain swapping in materials design

  2010cites this paper
• Cerebral amyloidosis: amyloid subunits, mutants and phenotypes

  2010cites this paper
• Cystatins and cancer.

  2009cites this paper
• Amyloids and Protein Aggregation-Analytical Methods

  2009cites this paper
• Governing the monomer-dimer ratio of human cystatin c by single amino acid substitution in the hinge region.

  2009cites this paper
• Folding, self-assembly, and bulk material properties of a de novo designed three-stranded beta-sheet hydrogel.

  2009cites this paper
• Structural basis of infectious and non-infectious amyloids.

  2008cites this paper
• Elucidation of the ribonuclease A aggregation process mediated by 3D domain swapping: a computational approach reveals possible new multimeric structures.

  2008cites this paper
• A unifying hypothesis for explaining the mechanism of amyloid formation under conditions of increased oxidative stress

  2008cites this paper
• Molecular Dynamics Simulations To Investigate the Domain Swapping Mechanism of Human Cystatin C

  2008cites this paper
• Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties.

  2007cites this paper
• Self-assembly of human latexin into amyloid-like oligomers

  2007cites this paper
• Oryzacystatin-II, a cystatin from rice (Oryza sativa L. japonica), is a dimeric protein: possible involvement of the interconversion between dimer and monomer in the regulation of the reactivity of oryzacystatin-II.

  2007cites this paper
• Protein aggregation in silico.

  2007cites this paper
• Molecular Dynamics Simulations of Human Cystatin C and Its L68Q Varient to Investigate the Domain Swapping Mechanism

  2007cites this paper
• Amyloid peptides and proteins in review.

  2007cites this paper
• Domain swapping as a molecular mechanism in amyloidosis

  2007cites this paper
• Functional characterization of extracellular protease inhibitors of phytophthora SPP and their targets tomato proteases

  2007cites this paper
• Fibrillogenic Oligomers of Human Cystatin C Are Formed by Propagated Domain Swapping*

  2007cites this paper
• Essential role of proline isomerization in stefin B tetramer formation.

  2007cites this paper
• Polyglutamine Expansion Diseases – the Case of Machado-Joseph Disease

  2007cites this paper
• The Role of Cystatin C in Cerebral Amyloid Angiopathy and Stroke: Cell Biology and Animal Models

  2006cites this paper
• Molecular structure of amyloid fibrils: insights from solid-state NMR

  2006cites this paper